SEC Filings | EyePoint Pharmaceuticals

Form	Description	Filing date	View
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Aug 28, 2006	View HTML 0001144204-06-035935.pdf 0001144204-06-035935.rtf 0001144204-06-035935.xls
UPLOAD	UPLOAD	Aug 22, 2006	View HTML 0000000000-06-040549.pdf
6-K/A	Amendment to a previously filed 6-K	Aug 14, 2006	View HTML 0001144204-06-033075.pdf 0001144204-06-033075.rtf 0001144204-06-033075.xls
F-3/A	Amendment to a previously filed F-3	Aug 14, 2006	View HTML 0000950123-06-010518.pdf 0000950123-06-010518.rtf 0000950123-06-010518.xls
F-3/A	Amendment to a previously filed F-3	Aug 14, 2006	View HTML 0000950123-06-010519.pdf 0000950123-06-010519.rtf 0000950123-06-010519.xls
F-3/A	Amendment to a previously filed F-3	Aug 14, 2006	View HTML 0000950123-06-010520.pdf 0000950123-06-010520.rtf 0000950123-06-010520.xls
CORRESP	CORRESP	Aug 14, 2006	View HTML 0000950123-06-010521.pdf 0000950123-06-010521.rtf 0000950123-06-010521.xls
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Jul 31, 2006	View HTML 0001144204-06-030238.pdf 0001144204-06-030238.rtf 0001144204-06-030238.xls
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Jul 31, 2006	View HTML 0001144204-06-030257.pdf 0001144204-06-030257.rtf 0001144204-06-030257.xls
6-K/A	Amendment to a previously filed 6-K	Jul 31, 2006	View HTML 0001144204-06-030277.pdf 0001144204-06-030277.rtf 0001144204-06-030277.xls

Data provided by Kaleidoscope.